SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-029126
Filing Date
2006-05-01
Accepted
2006-04-28 20:03:13
Documents
13
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-8976_110k.htm 10-K 1441536
2 EX-10 a06-8976_1ex10d22.htm EX-10.22 65614
3 EX-10 a06-8976_1ex10d23.htm EX-10.23 18697
4 EX-10 a06-8976_1ex10d24.htm EX-10.24 82948
5 EX-10 a06-8976_1ex10d25.htm EX-10.25 229762
6 EX-10 a06-8976_1ex10d26.htm EX-10.26 95564
7 EX-10 a06-8976_1ex10d27.htm EX-10.27 31047
8 EX-10 a06-8976_1ex10d28.htm EX-10.28 51930
9 EX-21 a06-8976_1ex21.htm EX-21 1913
10 EX-23 a06-8976_1ex23.htm EX-23 3649
11 EX-31 a06-8976_1ex31d1.htm EX-31.1 10849
12 EX-31 a06-8976_1ex31d2.htm EX-31.2 10661
13 EX-32 a06-8976_1ex32.htm EX-32 6427
  Complete submission text file 0001104659-06-029126.txt   2052217
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 06792020
SIC: 2834 Pharmaceutical Preparations